Akiki Dany, El Hage Said, El Masri Jad, Chanbour Wassef
General Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, LBN.
General Medicine, Faculty of Medical Sciences, Lebanese University, Hadath, LBN.
Cureus. 2022 Jan 25;14(1):e21593. doi: 10.7759/cureus.21593. eCollection 2022 Jan.
Purpose Our article aims to assess the epidemiology of eye cancer in Lebanon and compare it with other regions worldwide and to study its future trends among Lebanese males and females. Methods Data on eye cancer cases from 2005 to 2016 were obtained from the Lebanese National Cancer Registry (NCR). Age-specific rates, crude rates, and age-standardized rates (ASRs) were subsequently calculated. Joinpoint was used to determine the changes in the slope of trends. A projection for the next 14 years was predicted using linear and logarithmic regression models. Results Among all tumors, eye cancer ranked 40 in females and 41 in males. The eye cancer ASR was 0.24 and 0.22 per 100,000 in males and females, respectively. However, the mean age of eye cancer was 31.94 years in males and 22.04 years in females. The cumulative risk between 0 and 74 years was 0.02%. From 2004 till 2016, a negative trend of eye cancer was observed, with a parallelism of trends between males and females. Age-specific rates showed a bimodal distribution in males. The first cluster was witnessed in the age group of 0-4 years and the second one in those above 50. An additional cluster of distribution was observed in females between 35 and 44 years of age. Forecasts for the next 14 years revealed a steady rate of eye cancer incidence of about 0.2 per 100,000. Moreover, Lebanon showed a relatively low eye cancer ASR compared to other regions worldwide, especially Zimbabwe with 5.8 and 4.8 per 100,000 in females and males, respectively. Conclusion Ocular malignancies showed a negative trend of incidence. A 14-year projection predicts a steady incidence rate in Lebanon and worldwide. Eye cancer seems to be affected by many risk factors. Future efforts are needed for a better understanding of the disease and a better outcome.
目的 我们的文章旨在评估黎巴嫩眼癌的流行病学情况,并将其与世界其他地区进行比较,同时研究其在黎巴嫩男性和女性中的未来趋势。方法 从黎巴嫩国家癌症登记处(NCR)获取2005年至2016年眼癌病例的数据。随后计算年龄别发病率、粗发病率和年龄标准化发病率(ASR)。使用Joinpoint来确定趋势斜率的变化。使用线性和对数回归模型预测未来14年的情况。结果 在所有肿瘤中,眼癌在女性中排名第40,在男性中排名第41。男性和女性的眼癌ASR分别为每10万人0.24和0.22。然而,眼癌的平均年龄在男性中为31.94岁,在女性中为22.04岁。0至74岁之间的累积风险为0.02%。从2004年到2016年,观察到眼癌呈负趋势,男性和女性的趋势平行。年龄别发病率在男性中呈双峰分布。第一个高峰出现在0至4岁年龄组,第二个高峰出现在50岁以上人群。在35至44岁的女性中观察到另一个分布高峰。未来14年的预测显示,眼癌发病率稳定在每10万人约0.2例。此外,与世界其他地区相比,黎巴嫩的眼癌ASR相对较低,尤其是津巴布韦,女性和男性的ASR分别为每10万人5.8和4.8。结论 眼部恶性肿瘤的发病率呈负趋势。14年的预测表明黎巴嫩和全球的发病率将保持稳定。眼癌似乎受多种危险因素影响。未来需要做出更多努力以更好地了解该疾病并改善治疗结果。